Creative Biolabs provides peerless De Novo Chicken IgYs Sequencing Service, which has been developed based on our unique platform of De Novo Antibody Sequencing using our specific and world-leading â ....
Creative Biolabs is specialized in providing custom biotechnology and pharmaceutical services that cover the full scope of biotechnology needs of early drug discovery and drug development. As a....
The generation of human or humanized antibodies to human antigens is of particular interest for the treatment of a variety of diseases. Creative Biolabs is pleased to present world-leading De Novo....
Scientists from Creative Biolabs have developed â € œ Database Assisted Shotgun Sequencing" ( DASS) technology, which provides rodent antibody sequencing service. Our De Novo rodent antibody sequencing....
Creative Biolabs provides monoclonal antibodies sequencing service for biosimilar development, which provides full sequence coverage of the antibodies with 100% accuracy. Functional Biosimilar....
Creative Biolabs is pleased to introduce an unparalleled De Novo TCR ( T-cell Receptor) Sequencing service, which has been developed based on our world-leading platform of de novo antibody sequencing....
Creative Biolabs is pleased to introduce an unparalleled de novo Nanobody Sequencing service, which has been developed, based on our world-leading platform of de novo antibody sequencing using our....
Creative Biolabs has established a solid platform for DNA sequencing of both IgG and IgM types of monoclonal antibodies produced by mouse and rat hybridoma cell lines. The sequences of a monoclonal....
" Antibody characterization is important in research and biopharmaceutical development. All therapeutic proteins produced from current technologies have heterogeneities in the final product because....
" Creative Biolabs together with partners has developed an unparalleled platform of yeast target-based assays for antibody drug discovery. The use of these assays in the early phase of the screening....
Creative BioLabs offers a unique yeast display technology ( UltraffTM) for the discovery and optimization of monoclonal antibodies with pM affinity, the highest antibody affinity ever enabled by an....
Creative BioLabs has established to a unique ribosome display platform that is based on proprietary prokaryotic and eukaryotic ribosome display technologies. The ribosome display platform is a....
Creative BioLabs offers a unique bacterial display technology, Hi-affinityTM, for the development of human antibodies with pM affinity, the highest affinity ever enabled by an in vitro antibody....
Creative Biolabs organized a professional bioinformatics team to provide our customers with epitope prediction service. We employ a series of information integration methods and algorithms to....
3D-EM combines the power of electron microscopy ( EM) and bioinformatics to provide a new method for both linear and conformational epitope mapping. Epitope mapping by 3D-EM only requires very small....
LC-MS ( Liquid chromatographyâ € “ mass spectrometry) is another platform that Creative Biolabs developed for both linear and conformational epitope mapping. By combining limited proteolytic digestion, ....